253 related articles for article (PubMed ID: 16145543)
1. Loss of ER retention and sequestration of the wild-type ELOVL4 by Stargardt disease dominant negative mutants.
Karan G; Yang Z; Howes K; Zhao Y; Chen Y; Cameron DJ; Lin Y; Pearson E; Zhang K
Mol Vis; 2005 Aug; 11():657-64. PubMed ID: 16145543
[TBL] [Abstract][Full Text] [Related]
2. Expression of wild type and mutant ELOVL4 in cell culture: subcellular localization and cell viability.
Karan G; Yang Z; Zhang K
Mol Vis; 2004 Mar; 10():248-53. PubMed ID: 15073583
[TBL] [Abstract][Full Text] [Related]
3. Stargardt-like macular dystrophy protein ELOVL4 exerts a dominant negative effect by recruiting wild-type protein into aggresomes.
Vasireddy V; Vijayasarathy C; Huang J; Wang XF; Jablonski MM; Petty HR; Sieving PA; Ayyagari R
Mol Vis; 2005 Aug; 11():665-76. PubMed ID: 16163264
[TBL] [Abstract][Full Text] [Related]
4. Atrophic macular degeneration mutations in ELOVL4 result in the intracellular misrouting of the protein.
Ambasudhan R; Wang X; Jablonski MM; Thompson DA; Lagali PS; Wong PW; Sieving PA; Ayyagari R
Genomics; 2004 Apr; 83(4):615-25. PubMed ID: 15028284
[TBL] [Abstract][Full Text] [Related]
5. A novel mutation in the ELOVL4 gene causes autosomal dominant Stargardt-like macular dystrophy.
Maugeri A; Meire F; Hoyng CB; Vink C; Van Regemorter N; Karan G; Yang Z; Cremers FP; Zhang K
Invest Ophthalmol Vis Sci; 2004 Dec; 45(12):4263-7. PubMed ID: 15557430
[TBL] [Abstract][Full Text] [Related]
6. Dominant negative mechanism underlies autosomal dominant Stargardt-like macular dystrophy linked to mutations in ELOVL4.
Grayson C; Molday RS
J Biol Chem; 2005 Sep; 280(37):32521-30. PubMed ID: 16036915
[TBL] [Abstract][Full Text] [Related]
7. Sodium 4-phenylbutyrate acts as a chemical chaperone on misfolded myocilin to rescue cells from endoplasmic reticulum stress and apoptosis.
Yam GH; Gaplovska-Kysela K; Zuber C; Roth J
Invest Ophthalmol Vis Sci; 2007 Apr; 48(4):1683-90. PubMed ID: 17389500
[TBL] [Abstract][Full Text] [Related]
8. A novel gene for autosomal dominant Stargardt-like macular dystrophy with homology to the SUR4 protein family.
Edwards AO; Donoso LA; Ritter R
Invest Ophthalmol Vis Sci; 2001 Oct; 42(11):2652-63. PubMed ID: 11581213
[TBL] [Abstract][Full Text] [Related]
9. Coexpression and interaction of wild-type and missense RS1 mutants associated with X-linked retinoschisis: its relevance to gene therapy.
Dyka FM; Molday RS
Invest Ophthalmol Vis Sci; 2007 Jun; 48(6):2491-7. PubMed ID: 17525175
[TBL] [Abstract][Full Text] [Related]
10. Mutant ELOVL4 that causes autosomal dominant stargardt-3 macular dystrophy is misrouted to rod outer segment disks.
Agbaga MP; Tam BM; Wong JS; Yang LL; Anderson RE; Moritz OL
Invest Ophthalmol Vis Sci; 2014 May; 55(6):3669-80. PubMed ID: 24833735
[TBL] [Abstract][Full Text] [Related]
11. Wild-type and missense mutants of retinoschisin co-assemble resulting in either intracellular retention or incorrect assembly of the functionally active octamer.
Gleghorn LJ; Trump D; Bulleid NJ
Biochem J; 2009 Dec; 425(1):275-83. PubMed ID: 19849666
[TBL] [Abstract][Full Text] [Related]
12. Does lens intrinsic membrane protein MP19 contain a membrane-targeting signal?
Chen T; Li X; Yang Y; Erdene AG; Church RL
Mol Vis; 2003 Dec; 9():735-46. PubMed ID: 14735063
[TBL] [Abstract][Full Text] [Related]
13. Epitope tagging of the human endoplasmic reticulum HSP70 protein, BiP, to facilitate analysis of BiP--substrate interactions.
Murray PJ; Watowich SS; Lodish HF; Young RA; Hilton DJ
Anal Biochem; 1995 Aug; 229(2):170-9. PubMed ID: 7485969
[TBL] [Abstract][Full Text] [Related]
14. Upregulation of BiP and CHOP by the unfolded-protein response is independent of presenilin expression.
Sato N; Urano F; Yoon Leem J; Kim SH; Li M; Donoviel D; Bernstein A; Lee AS; Ron D; Veselits ML; Sisodia SS; Thinakaran G
Nat Cell Biol; 2000 Dec; 2(12):863-70. PubMed ID: 11146649
[TBL] [Abstract][Full Text] [Related]
15. Diverse macular dystrophy phenotype caused by a novel complex mutation in the ELOVL4 gene.
Bernstein PS; Tammur J; Singh N; Hutchinson A; Dixon M; Pappas CM; Zabriskie NA; Zhang K; Petrukhin K; Leppert M; Allikmets R
Invest Ophthalmol Vis Sci; 2001 Dec; 42(13):3331-6. PubMed ID: 11726641
[TBL] [Abstract][Full Text] [Related]
16. Intracellular sequestration of hetero-oligomers formed by wild-type and glaucoma-causing myocilin mutants.
Gobeil S; Rodrigue MA; Moisan S; Nguyen TD; Polansky JR; Morissette J; Raymond V
Invest Ophthalmol Vis Sci; 2004 Oct; 45(10):3560-7. PubMed ID: 15452063
[TBL] [Abstract][Full Text] [Related]
17. Evidence for a role of transmembrane protein p25 in localization of protein tyrosine phosphatase TC48 to the ER.
Gupta V; Swarup G
J Cell Sci; 2006 May; 119(Pt 9):1703-14. PubMed ID: 16595549
[TBL] [Abstract][Full Text] [Related]
18. Expression of wild-type and truncated myocilins in trabecular meshwork cells: their subcellular localizations and cytotoxicities.
Sohn S; Hur W; Joe MK; Kim JH; Lee ZW; Ha KS; Kee C
Invest Ophthalmol Vis Sci; 2002 Dec; 43(12):3680-5. PubMed ID: 12454036
[TBL] [Abstract][Full Text] [Related]
19. Intracellular entrapment of wild-type TSH receptor by oligomerization with mutants linked to dominant TSH resistance.
Calebiro D; de Filippis T; Lucchi S; Covino C; Panigone S; Beck-Peccoz P; Dunlap D; Persani L
Hum Mol Genet; 2005 Oct; 14(20):2991-3002. PubMed ID: 16135555
[TBL] [Abstract][Full Text] [Related]
20. [Comparative study of eukaryotic cell expression of wild-type and Pro370Leu mutation type myocilin gene].
Wang JW; Sun HM; Ji J; Li XR; Zheng JQ
Zhonghua Yi Xue Za Zhi; 2006 Mar; 86(10):700-4. PubMed ID: 16681932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
